product summary
Loading...
company name :
Sino Biological
product type :
protein
product name :
SARS-CoV Spike/S1 Protein (S1 Subunit, His Tag)
catalog :
40150-V08B1
quantity :
100 µg
price :
448 USD
more info or order :
Sino Biological product webpage
citations: 27
Published Application/Species/Sample/DilutionReference
  • ELISA; SARS coronavirus
Wang S, Peng Y, Wang R, Jiao S, Wang M, Huang W, et al. Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys. Nat Commun. 2020;11:5752 pubmed publisher
Bong Y, Brown D, Chung E, Ananthaswamy N, Chen R, Lewoczko E, et al. S6P mutation in Delta and Omicron variant spike protein significantly enhances the efficacy of mRNA COVID-19 vaccines. Front Immunol. 2024;15:1495561 pubmed publisher
Brustoloni C, Soltan Khamsi P, Kammarchedu V, Ebrahimi A. Systematic Study of Various Functionalization Steps for Ultrasensitive Detection of SARS-CoV-2 with Direct Laser-Functionalized Au-LIG Electrochemical Sensors. ACS Appl Mater Interfaces. 2024;16:49041-49052 pubmed publisher
Zhang J, Li Y, Zeng F, Mu C, Liu C, Wang L, et al. Virus-like structures for combination antigen protein mRNA vaccination. Nat Nanotechnol. 2024;19:1224-1233 pubmed publisher
Liu S, Chen H, Chen X, Luo N, Peraramelli S, Gong X, et al. Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection. Front Immunol. 2024;15:1365803 pubmed publisher
Li H, Gong H, Wong T, Zhou J, Wang Y, Lin L, et al. Wireless, battery-free, multifunctional integrated bioelectronics for respiratory pathogens monitoring and severity evaluation. Nat Commun. 2023;14:7539 pubmed publisher
D Arco A, Di Fabrizio M, Mancini T, Mosetti R, Macis S, Tranfo G, et al. Secondary Structures of MERS-CoV, SARS-CoV, and SARS-CoV-2 Spike Proteins Revealed by Infrared Vibrational Spectroscopy. Int J Mol Sci. 2023;24: pubmed publisher
Gary E, Tursi N, Warner B, Cuismano G, Connors J, Parzych E, et al. Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge. Front Immunol. 2023;14:1138609 pubmed publisher
Mu xf1 oz Basagoiti J, Monteiro F, Krumpe L, Armario Najera V, Shenoy S, Perez Zsolt D, et al. Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2. Proc Natl Acad Sci U S A. 2023;120:e2214561120 pubmed publisher
Marzi R, Bassi J, Silacci Fregni C, Bartha I, Muoio F, Culap K, et al. Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape. iScience. 2023;26:105726 pubmed publisher
Karunakaran V, Joseph M, Yadev I, Sharma H, Shamna K, Saurav S, et al. A non-invasive ultrasensitive diagnostic approach for COVID-19 infection using salivary label-free SERS fingerprinting and artificial intelligence. J Photochem Photobiol B. 2022;234:112545 pubmed publisher
Cieslewicz B, Makrinos D, Burke H, Bree D, Haridas R, Tonkiss I, et al. Preclinical Immunogenicity and Efficacy of a Multiple Antigen-Presenting System (MAPSTM) SARS-CoV-2 Vaccine. Vaccines (Basel). 2022;10: pubmed publisher
Zamzami M, Rabbani G, Ahmad A, Basalah A, Al Sabban W, Nate Ahn S, et al. Carbon nanotube field-effect transistor (CNT-FET)-based biosensor for rapid detection of SARS-CoV-2 (COVID-19) surface spike protein S1. Bioelectrochemistry. 2022;143:107982 pubmed publisher
Ohtsuka J, Imai M, Fukumura M, Maeda M, Eguchi A, Ono R, et al. Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2. iScience. 2021;24:103379 pubmed publisher
Bertoglio F, Meier D, Langreder N, Steinke S, Rand U, Simonelli L, et al. SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface. Nat Commun. 2021;12:1577 pubmed publisher
Huang K, Tan T, Chen T, Huang C, Harvey R, Hussain S, et al. Breadth and function of antibody response to acute SARS-CoV-2 infection in humans. PLoS Pathog. 2021;17:e1009352 pubmed publisher
Hanson Q, Wilson K, Shen M, Itkin Z, Eastman R, Shinn P, et al. Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay. ACS Pharmacol Transl Sci. 2020;3:1352-1360 pubmed publisher
Haun B, Lai C, Williams C, Wong T, Lieberman M, Pessaint L, et al. CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization. Front Immunol. 2020;11:599587 pubmed publisher
Liu T, Hsiung J, Zhao S, Kost J, Sreedhar D, Hanson C, et al. Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates. Nat Biomed Eng. 2020;4:1188-1196 pubmed publisher
Torrente Rodríguez R, Lukas H, Tu J, Min J, Yang Y, Xu C, et al. SARS-CoV-2 RapidPlex: A Graphene-Based Multiplexed Telemedicine Platform for Rapid and Low-Cost COVID-19 Diagnosis and Monitoring. Matter. 2020;3:1981-1998 pubmed publisher
Chi X, Liu X, Wang C, Zhang X, Li X, Hou J, et al. Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain. Nat Commun. 2020;11:4528 pubmed publisher
Gorshkov K, Susumu K, Chen J, Xu M, Pradhan M, Zhu W, et al. Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis. ACS Nano. 2020;14:12234-12247 pubmed publisher
Hanson Q, Wilson K, Shen M, Itkin Z, Eastman R, Shinn P, et al. Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay. bioRxiv. 2020;: pubmed publisher
Smith T, Patel A, Ramos S, Elwood D, Zhu X, Yan J, et al. Immunogenicity of a DNA vaccine candidate for COVID-19. Nat Commun. 2020;11:2601 pubmed publisher
Pinto D, Park Y, Beltramello M, Walls A, Tortorici M, Bianchi S, et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020;583:290-295 pubmed publisher
Long Q, Liu B, Deng H, Wu G, Deng K, Chen Y, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26:845-848 pubmed publisher
Grunwald C. Analysis of free phytosterols by gas chromatography using liquid phase OV-101. J Chromatogr. 1969;44:173-5 pubmed
image
image 1 :
Sino Biological 40150-V08B1 image 1
product information
Catalog Number :
40150-V08B1
Product Name :
SARS-CoV Spike/S1 Protein (S1 Subunit, His Tag)
Product Type :
Protein
Host Species :
Baculovirus-Insect Cells
Conjugation :
C-His
Size :
100 µg
List Price :
448 USD
Gene ID :
AAX16192.1
Product Description :
A DNA sequence encoding the S1 subunit of SARS-CoV (isolate:WH20) spike (AAX16192.1) (Met1-Arg667) was expressed with a C-terminal polyhistidine tag.
SpeciesSummary :
SARS
ALTnames :
Spike
Purity :
> 90 % as determined by SDS-PAGE
Buffer :
Lyophilized from sterile 20 mM Tris, 300 mM NaCl, 10% glycerol, pH 7.5.
Packaging :
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Storage :
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
more info or order :
Sino Biological product webpage
company information
Sino Biological
Building 9, No.18 Kechuang 10th St, BDA, Beijing, 100176
marketing@sinobiological.com
https://www.sinobiological.com
86 400-890-9989
headquarters: China
Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones. Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements. In addition, Sino Biological offer pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates.